Case Reports in Dermatological Medicine

Aims & Scope

Case Reports in Dermatological Medicine is a peer-reviewed, Open Access journal that publishes case reports and case series covering prevention, diagnosis, and treatment of disorders of the skin, hair, and nails.

The journal also encourages submissions looking at the use of novel technologies in the area of diagnosis and treatment.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 750.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Mesenchymal Stem Cell Conditioned Media Ameliorate Psoriasis Vulgaris: A Case Study

  Citation: 26

  Authors: Rajasekar, Anjum, Prashant, Divyang, Anand

• Effects of Cryolipolysis on Abdominal Adiposity

  Citation: 17

  Authors: Patricia Froes, Rodrigo Marcel Valentim da, Glenda, Maely Azevedo da Silva, Melyssa Lima, Camila Procopio, Luis Gonzaga de Araujo

• Dramatic Clinical Response of Relapsed Metastatic Extramammary Paget’s Disease to Trastuzumab Monotherapy

  Citation: 15

  Authors: S., Y., K., K., N., H.

• Successful Treatment of Plaque Psoriasis with Allogeneic Gingival Mesenchymal Stem Cells: A Case Study

  Citation: 15

  Authors: Sebo Gene, Nicholas C., Sebo Michelle, Fu Nan

• Therapeutic Response to Secukinumab in a 36-Year-Old Woman with Hidradenitis Suppurativa

  Citation: 13

  Authors: Astrid-Helene Ravn, Yiqiu, Simon Francis

• Acute Methotrexate Toxicity: A Fatal Condition in Two Cases of Psoriasis

  Citation: 12

  Authors: Pankti, Vinay, Khyati, Sejal, Dipak Dayabhai

• Large Fibroepithelial Polyp of Vulva

  Citation: 11

  Authors: Mahesha H., Poornima Ramachandra B., Sujaya V., Nagarathna

• New-Onset Bullous Pemphigoid in a COVID-19 Patient

  Citation: 11

  Authors: Natalie, David, Angela

• Erosive Pustular Dermatosis of the Scalp Induced by Imiquimod

  Citation: 11

  Authors: Maria Teresa, Marina, Erika, Renzo, Anna, Mauro

• Combination of Infliximab and High-Dose Intravenous Immunoglobulin for Toxic Epidermal Necrolysis: Successful Treatment of an Elderly Patient

  Citation: 10

  Authors: Konstantinos, Anastasios, Konstantinos, Dimitrios, Christos, Georgios, Ioannis D.